(Q35669234)

English

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification

scientific article published on 9 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

9

object named as

Bart Barlogie

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Owen W Stephens

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Qing Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Pingping Qu

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Yiming Zhou

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Shweta Chavan

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Erming Tian

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

David R Williams

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Joshua Epstein

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

John D Shaughnessy

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

9 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

119

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

503-512

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

The molecular characterization and clinical management of multiple myeloma in the post-genome era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Identification of common genetic variation that modulates alternative splicing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Jumping translocations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

The molecular classification of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transpla

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Interleukin-6: from basic science to medicine--40 years in immunology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Catalytic properties of ADAM19

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

The soluble interleukin 6 receptor: mechanisms of production and implications in disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Prognosis in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Interleukin-6 prevents dexamethasone-induced myeloma cell death.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Interleukin-6 in human multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

12 July 2018

An emerging 1q21.1 deletion-associated neurodevelopmental phenotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

25 September 2018

Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

25 September 2018

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

25 September 2018

Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

25 September 2018

Cancer and the microenvironment: myeloma-osteoclast interactions as a model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

25 September 2018

Identification of novel SNPs in the interleukin 6 receptor gene (IL6R).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

25 September 2018

Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3257015

25 September 2018

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2011-07-367052

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35669234&oldid=1583122335"